Fighting Breast and Ovarian Cancer With a Lupus Antibody
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
Sex Differences in Gastrointestinal Cancer
With this year's Wendy U. and Thomas C. Naratil Pioneer Award and co-funding from the Yale Cancer Center, Dr. Pamela Kunz is conducting one of the first studies to examine sex differences in treating neuroendocrine neoplasms (NENs), a rare form of cancer often found in the gastrointestinal tract.
Using Particles That Are Smaller Than the Head of a Pin to Treat Cancer
Thanks in part to research begun more than a decade ago with funding from Women’s Health Research at Yale, Dr. W. Mark Saltzman is working with colleagues on a way to deploy effective cancer-fighting medication safely with the help of nanoparticles.
Treatment with Genetically Altered Viruses Targets and Destroys Ovarian Cancer in Mice
Researchers have successfully eliminated chemotherapy-resistant ovarian cancer cells in mice using a single injection of two viruses genetically combined and altered to be safe, leading to long-term survival and demonstrating a potential breakthrough treatment for women.
Once-Common Hysterectomy Technique Linked to Worse Uterine Cancer Outcomes
Every year, nearly 700,000 American women have surgery to remove their uterus (hysterectomy) or uterine fibroids (myomectomy). A laparoscopic surgical technique once commonly used in these procedures could be worsening the outcomes for women who have undiagnosed uterine cancer at the time of the procedure, Yale Cancer Center scientists report in the Journal of Clinical Oncology.
Statement concerning recall of Allergan breast implants following cancer link
At the request of the U.S. Food and Drug Administration, textured breast implants made by Allergan are being recalled. The implants have been linked to a rare cancer called Anaplastic Large Cell Lymphoma. Dr. Tomer Avraham comments.
Expanded insurance coverage for breast cancer screenings lauded by officials, advocates
Harrowing tales from breast cancer survivors from across the state and a slip-up from a freshman legislator are among the circumstances that led to the passage of a bill expanding health care coverage for annual breast cancer screenings.Source: CT Mirror
More women in U.S. receive 3-D mammography but disparities remain
Use of 3-D mammography, an advanced form of breast cancer screening, has risen rapidly in recent years, according to Yale Cancer Center researchers in a new study. But adoption of the technology varies widely, reflecting emerging disparities in care, they said.
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as CT Magazine 'Best Doctors'
Connecticut Magazine has named 72 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2019 Best Doctors guide. Published in the magazine’s June issue, the Best Doctors list consists of 782 Connecticut physicians from 78 medical specialties.
8 Ways to Be There for Yourself After a Breast Cancer Diagnosis
Although learning to cope after a breast cancer diagnosis is a really individual process, experts and survivors we spoke with emphasized that there are a few ways you might be able to make the experience even a little bit easier. Here are their suggestions.Source: Self Magazine
Greenwich woman helps lead early detection battle against ovarian, breast cancers
GREENWICH — Greenwich Hospital will spearhead an effort to help doctors better recognize the symptoms and signs of ovarian cancer and breast cancer and more effectively diagnose the potentially deadly diseases.Source: Greenwich Time
Greenwich Hospital and the Town of Greenwich partner to announce a new program to screen earlier for Breast and Ovarian Cancers
Greenwich, CT (May 1, 2019) – Greenwich Hospital will launch a new physician education program to help all doctors recognize potential early signs of breast and ovarian cancer in an effort to diagnose both diseases much sooner. Called the MAT Education Program, the curriculum was developed by physicians at Smilow Cancer Hospital at Yale New Haven and Yale Cancer Center at the behest of Greenwich resident Kaile Josephs Zagger who lost her mother, Marilyn Ann Trahan (MAT) 20 years ago to ovarian cancer.
Breaking it Down: How the Chemistry of Digestion is Uncovering Sex-Specific Causes of Colon Cancer
A new technology called metabolomics allows researchers to explore the small chemicals formed and used during digestion as a window into the formation of diseases such as colon cancer, seeking early warning signs and potent tactics for prevention.